Gossamer Bio, Inc. GOSS
- seralutinib — Pulmonary Arterial Hypertension Phase 3
- seralutinib — Pulmonary Hypertension associated with Interstitial Lung Disease Phase 3
PDGFR (1 companies · 2 programs)
Companies with an active program directed at PDGFR.
Companies with an active program directed at PDGFR.